Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resistant cancers

Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resistant cancers

US Patent 9034840 · Granted May 19, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resis2018
Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resis2018
Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resis2018
Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resis2018
Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resis2018
Hydrophobically modified antisense oligonucleotides comprising a triple alkyl ch2017
Hydrophobically modified antisense oligonucleotides comprising a triple alkyl ch2017
Hydrophobically modified antisense oligonucleotides comprising a ketal group2017
Hydrophobically modified antisense oligonucleotides comprising a ketal group2017
Compositions and methods for treatment of prostate and other cancers2017
Compositions and methods for treatment of prostate and other cancers2016
Compositions and methods for treatment of prostate and other cancers2015